Reich Kristian

Chief Scientific OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Feb 16, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.7M
Net Open-Market Flow
-$3.7M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2024Sell(S)10K$60.15$602K3.0M
Feb 16, 2024Sell(S)10K$60.15$602K110K
Feb 15, 2024Sell(S)10K$60.17$602K3.0M
Feb 15, 2024Sell(S)10K$60.16$602K120K
Feb 14, 2024Sell(S)10K$62.43$624K130K
Feb 14, 2024Sell(S)10K$62.42$624K3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-014996) within minutes of acceptance. Every field above traces to the original document. Verify it directly: